SCHEMBL756464

SCHEMBL756464

C=CCC1(CC=C)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557480 1.00
SCHEMBL2048269 0.89 L3MBTL1 (0.30)
SCHEMBL6701576 0.85 ALDH1A1 (0.30)
SCHEMBL3962663 0.84 TUBB4A (0.31)
SCHEMBL3962665 0.84 TUBB4A (0.31)
SCHEMBL11796688 0.84
SCHEMBL2049280 0.82
SCHEMBL2049284 0.82
SCHEMBL2049286 0.76
SCHEMBL2049289 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023152691-A1 PROCESS FOR THE PREPARATION OF PONESIMOD AND ITS INTERMEDIATES THEREOF METROCHEM API PVT LTD (IN) 2023-08-17 WO claimed
EP-3066093-B9 GSK-3 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-02-07 EP claimed
EP-3066093-B1 GSK-3 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-04 EP claimed
US-9718804-B2 GSK-3 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-08-01 US claimed
US-20160272621-A1 GSK-3 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-09-22 US claimed
EP-3066093-A1 GSK-3 INHIBITORS Bristol-Myers Squibb Company (US) 2016-09-14 EP claimed
WO-2015069594-A1 GSK-3 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-05-14 WO claimed
EP-2327705-A1 Podophyllotoxins as antiproliferative agents Universitätsklinikum Charité der Humboldt- Universität zu Berlin (DE) 2011-06-01 EP claimed
US-20060293254-A1 enzyme inhibitors of topoisomerase as anticancer, antitumor, antifungal and/or microbiocides; ; etoposide and teniposide; prodrugs; water solubility, stability UNIVERSITATSKLINIKUM CHARITE DER HUMBOLDT-UNIVERSITAT ZU (DE) 2006-12-28 US claimed
EP-1451193-A1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS Universitätsklinikum Charité der Humboldt- Universität zu Berlin (DE) 2004-09-01 EP claimed
WO-2003048166-A1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS UNIVERSITÄTSKLINIKUM CHARITE DER HUMBOLDT-UNIVERSITÄT ZU BERLIN TECHNOLOGIE TRANSFERSTELLE (DE) 2003-06-12 WO claimed
EP-3737673-B1 PROCESS FOR PREPARING HALICHONDRIN MACROLIDES AND ANALOGS THEREOF BY A PRINS REACTION, AND INTERMEDIATES OF THIS PROCESS EISAI R&D MAN CO LTD (JP) 2024-03-06 EP disclosed
WO-2023152691-A1 PROCESS FOR THE PREPARATION OF PONESIMOD AND ITS INTERMEDIATES THEREOF METROCHEM API PVT LTD (IN) 2023-08-17 WO disclosed
US-11713329-B2 Intermediates useful in the preparation of halichondrin compounds and methods for preparing the same BEIJING TIENYI LUFU PHARMATECH CO. LTD. (CN) 2023-08-01 US disclosed
US-20230151022-A1 PRINS REACTION AND COMPOUNDS USEFUL IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ANALOGS THEREOF EISAI R&D MANAGEMENT CO, LTD. (JP) 2023-05-18 US disclosed
US-20050287473-A1 Photosensitive composition and method for forming pattern using the same FUJI PHOTO FILM CO., LTD. 2005-12-29 US disclosed
US-20050239829-A1 Novel piperidine compound TANABE SEIYAKU CO. LTD. (JP) 2005-10-27 US disclosed
EP-1451193-A1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS Universitätsklinikum Charité der Humboldt- Universität zu Berlin (DE) 2004-09-01 EP disclosed
WO-2003048166-A1 PODOPHYLLOTOXINS AS ANTIPROLIFERATIVE AGENTS UNIVERSITÄTSKLINIKUM CHARITE DER HUMBOLDT-UNIVERSITÄT ZU BERLIN TECHNOLOGIE TRANSFERSTELLE (DE) 2003-06-12 WO disclosed
JP-2001199977-A METHOD FOR PRODUCING 2,2-DIALKYL-1,3-DIOXOLANE COMPOUND UBE IND LTD 2001-07-24 JP disclosed